Mass. Medicaid To Establish Quantity Limit For Short-Acting Beta-2 Agonists
Executive Summary
Massachusetts Medicaid will establish a quantity limit for short-acting beta-2 agonists to encourage physicians to alter "inadequate" anti-inflammatory therapy